Zentalis Pharmaceuticals Inc logo

Zentalis Pharmaceuticals Inc (ZNTL) live share price

Zentalis Pharmaceuticals Inc share price in USD $3.61 & INR ₹305.19

$3.61

-0.02

(-0.55%)

View live Zentalis Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Zentalis Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Zentalis Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Zentalis Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Zentalis Pharmaceuticals Inc's financials.

Zentalis Pharmaceuticals Inc share price movements

  • $3.60
    $3.73

    Day's Volatility :3.49%

  • $2.66
    $18.07

    52 Weeks Volatility :85.28%

Zentalis Pharmaceuticals Inc Returns

PeriodZentalis Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
11.76%
-6.2%
0.0%
6 Months
-68.33%
2.6%
0.0%
1 Year
-68.77%
11.8%
0.0%
3 Years
-95.03%
13.8%
-17.6%

Zentalis Pharmaceuticals Inc Key Statistics

in dollars & INR

Market Capitalization
$258.7M
Revenue TTM
$40.6M
EBITDA
$-208.0M
Earnings Per Share (EPS)
$-2.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.89%

How to invest in Zentalis Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Zentalis Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zentalis Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Zentalis Pharmaceuticals Inc or ZNTL on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zentalis Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zentalis Pharmaceuticals Inc shares which would translate to 0.234 fractional shares of Zentalis Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Zentalis Pharmaceuticals Inc

-14%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Zentalis Pharmaceuticals Inc on INDmoney from India has reduced in the last 30 days as on Dec 2, 2024. -14% less investors are searching Zentalis Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Zentalis Pharmaceuticals Inc

  • Matrix Capital Management Company, LLC

    19.62%

  • Eventide Asset Management, LLC

    12.01%

  • FMR Inc

    7.13%

  • BlackRock Inc

    6.77%

  • Vanguard Group Inc

    6.48%

  • Morgan Stanley - Brokerage Accounts

    5.48%

Analyst Recommendation on Zentalis Pharmaceuticals Inc

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Zentalis Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Zentalis Pharmaceuticals Inc

What analysts predicted

Upside of 163.16%

Current:

$3.61

Target:

$9.50

Insights on Zentalis Pharmaceuticals Inc

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 115.8%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 40.6% return, outperforming this stock by 135.7%

Zentalis Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Zentalis Pharmaceuticals Inc is currently in a neutral trading position according to technical analysis indicators.

Zentalis Pharmaceuticals Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zentalis Pharmaceuticals Inc
-3.22%
-68.33%
-68.77%
-95.03%
-84.44%
Regeneron Pharmaceuticals, Inc.
-11.07%
-24.18%
-8.88%
18.12%
102.78%
Biontech Se
6.2%
15.09%
18.5%
-65.59%
454.0%
Alnylam Pharmaceuticals, Inc.
-7.61%
68.21%
46.39%
47.68%
107.47%
Vertex Pharmaceuticals Incorporated
-0.63%
-0.44%
33.51%
129.69%
109.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zentalis Pharmaceuticals Inc
NA
NA
NA
-2.39
-0.43
-0.25
NA
4.98
Regeneron Pharmaceuticals, Inc.
18.66
18.66
1.12
44.91
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.22
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zentalis Pharmaceuticals Inc
Buy
$258.7M
-84.44%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
102.78%
18.66
33.61%
Biontech Se
Buy
$28.9B
454.0%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
107.47%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$119.6B
109.07%
32.84
-4.51%

About Zentalis Pharmaceuticals Inc

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer
Organization
Zentalis Pharmaceuticals Inc
Employees
124
CEO
Ms. Andrea Paul J.D.
Industry
Health Technology

Important FAQs about investing in Zentalis Pharmaceuticals Inc from India :

What is Zentalis Pharmaceuticals Inc share price today?

Zentalis Pharmaceuticals Inc (ZNTL) share price today is $3.61.

Can Indians buy Zentalis Pharmaceuticals Inc shares?

Yes, Indians can invest in the Zentalis Pharmaceuticals Inc (ZNTL) from India.

With INDmoney, you can buy Zentalis Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Zentalis Pharmaceuticals Inc at zero transaction cost.

How can I buy Zentalis Pharmaceuticals Inc shares from India?

It is very easy to buy Zentalis Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zentalis Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Zentalis Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Zentalis Pharmaceuticals Inc stocks?

To start investing in Zentalis Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Zentalis Pharmaceuticals Inc

Today’s highest price of Zentalis Pharmaceuticals Inc (ZNTL) is $3.73.

Today’s lowest price of Zentalis Pharmaceuticals Inc (ZNTL) is $3.60.

What is today's market capitalisation of Zentalis Pharmaceuticals Inc

Today's market capitalisation of Zentalis Pharmaceuticals Inc ZNTL is 258.7M

What is the 52 Week High and Low Range of Zentalis Pharmaceuticals Inc

  • 52 Week High

    $18.07

  • 52 Week Low

    $2.66

How much percentage Zentalis Pharmaceuticals Inc is down from its 52 Week High?

Zentalis Pharmaceuticals Inc (ZNTL) share price is $3.61. It is down by 99% from its 52 Week High price of $18.07.

How much percentage Zentalis Pharmaceuticals Inc is up from its 52 Week low?

Zentalis Pharmaceuticals Inc (ZNTL) share price is $3.61. It is up by 1% from its 52 Week Low price of $2.66.

What are the historical returns of Zentalis Pharmaceuticals Inc?

  • 1 Month Returns

    -3.22%

  • 3 Months Returns

    -68.33%

  • 1 Year Returns

    -68.77%

  • 5 Years Returns

    -84.44%

Who is the Chief Executive Officer (CEO) of Zentalis Pharmaceuticals Inc

Ms. Andrea Paul J.D. is the current Chief Executive Officer (CEO) of Zentalis Pharmaceuticals Inc.